Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
18.56B | 11.81B | 11.91B | 12.22B | 11.50B | Gross Profit |
6.42B | 3.00B | 3.26B | 4.46B | 4.18B | EBIT |
5.75B | 708.00M | 1.46B | 1.74B | 2.82B | EBITDA |
7.87B | 1.86B | 3.28B | 5.54B | 6.10B | Net Income Common Stockholders |
3.35B | -2.52B | -506.00M | 10.00M | 2.83B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.64B | 3.02B | 3.76B | 5.07B | 5.83B | Total Assets |
56.35B | 55.51B | 38.48B | 40.56B | 41.37B | Total Debt |
8.97B | 9.44B | 6.13B | 6.30B | 6.70B | Net Debt |
-3.12B | 6.43B | 3.25B | 1.31B | 1.16B | Total Liabilities |
26.24B | 26.30B | 18.95B | 18.70B | 17.49B | Stockholders Equity |
30.11B | 29.03B | 19.35B | 22.02B | 23.01B |
Cash Flow | Free Cash Flow | |||
6.36B | 97.00M | 1.09B | 2.63B | 3.58B | Operating Cash Flow |
6.36B | 2.76B | 3.22B | 4.28B | 4.88B | Investing Cash Flow |
-2.70B | -1.00B | -2.98B | -1.87B | 91.00M | Financing Cash Flow |
-2.95B | -1.60B | -2.36B | -2.96B | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $69.77B | 26.70 | 9.10% | 1.66% | 26.99% | -6.63% | |
78 Outperform | $15.30B | 13.04 | 0.90% | 0.74% | 9.18% | ― | |
75 Outperform | $19.78B | 15.21 | 11.11% | 1.13% | 16.53% | 206.89% | |
73 Outperform | $44.35B | 15.31 | 8.83% | 2.29% | 15.40% | 72.49% | |
66 Neutral | $47.90B | 14.88 | 11.13% | 2.35% | 58.27% | ― | |
63 Neutral | $2.86B | ― | -8.41% | 0.76% | -29.09% | -157.10% | |
47 Neutral | $2.64B | -4.00 | -31.55% | 3.33% | 2.93% | -29.90% |